You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 12, December 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Head & Neck Cancer
 •Otolaryngology/ Head & Neck Surgery
 •Dermatologic Disorders
 •Pediatrics
 •Neonatology and Infant Care
 •Hemangiomas
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Infantile Hemangiomas

How to Know When They Grow

Maurice A. M. van Steensel, MD, PhD

Arch Dermatol. 2008;144(12):1650.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Infantile hemangioma (IH) is the most common tumor of infancy. Although its biologic properties are still quite mysterious, its clinical characteristics are for the most part well delineated. Thus, we know that a typical hemangioma will grow rapidly during infancy followed by a gradual involution. Most IHs will grow for about 6 months. As a consequence, clinical treatment is conservative, and intervention is usually reserved for IHs that threaten organ function (eg, those with intraorbital growth). Because medical treatment involves drugs such as methylprednisolone or interferon alfa, clinicians are usually not too keen on intervening unless they really have to. In a number of cases, growth will be prolonged. If this occurs near vital structures, it might become a problem and would be a good indication for early intervention. Unfortunately, at present there is not a reliable set of criteria to help us . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Infantile Hemangiomas With Unusually Prolonged Growth Phase: A Case Series
Heather A. Brandling-Bennett, Denise W. Metry, Eulalia Baselga, Anne W. Lucky, Denise M. Adams, Maria R. Cordisco, and Ilona J. Frieden
Arch Dermatol. 2008;144(12):1632-1637.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Infantile Hemangiomas with Prolonged Growth
Journal Watch Dermatology 2009;2009:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.